Evoke Pharma Inc — key financial figures for fiscal year 2024 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2024)

$10.2M

Net Income/Loss (FY2024)

-$5.4M

Total Assets (FY2024)

$17.5M

Total Equity (FY2024)

$7.0M

Cash Flows from Operating Activities (FY2024)

-$5.5M

Source: Evoke Pharma Inc 10-K filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.